New Enterprise Associates 14, L.P.

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 35% 68% 82%
Transactions
23 4% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -89%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
New Enterprise Associates 14, L.P.'s trades of Adaptimmune Therapeutics PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-15 2025-08-15
PrS Proposed sale
37,014
406.22
US$3,497,120 		37,014 406.22 US$3,497,120
2025-08-15 2025-08-15
PrS Proposed sale
24,554
344.49
US$1,444,122 		24,554 344.49 US$1,444,122
2024-07-17 2024-07-17
US Tuya Inc (TUYA)
PrS Proposed sale
99,163
47.07
US$1,705,591 		99,163 47.07 US$1,705,591
2024-04-19 2024-04-19
US Tuya Inc (TUYA)
PrS Proposed sale
4,539,242
1.64
US$7,448,896 		4,539,242 1.64 US$7,448,896
2022-04-07 2022-04-06
S Sale
255,463 -8.9%
1.10
US$281,827 		255,463 -8.9% 1.10 US$281,827
2022-04-07 2022-04-05
S Sale
439,088 -13.3%
1.07
US$469,429 		439,088 -13.3% 1.07 US$469,429
2022-01-25 2022-01-25
S Sale
102,952 -3.0%
1.47
US$151,803 		102,952 -3.0% 1.47 US$151,803
2022-01-25 2022-01-24
S Sale
19,984 -0.6%
1.55
US$31,017 		19,984 -0.6% 1.55 US$31,017
2022-01-25 2022-01-21
S Sale
11,622 -0.3%
1.67
US$19,389 		11,622 -0.3% 1.67 US$19,389
2022-01-20 2022-01-20
S Sale
6,295 -0.2%
1.81
US$11,385 		6,295 -0.2% 1.81 US$11,385
2022-01-20 2022-01-19
S Sale
13,412 -0.4%
1.82
US$24,414 		13,412 -0.4% 1.82 US$24,414
2022-01-20 2022-01-18
S Sale
6,848 -0.2%
1.89
US$12,927 		6,848 -0.2% 1.89 US$12,927
2022-01-14 2022-01-14
S Sale
9,707 -0.3%
1.91
US$18,583 		9,707 -0.3% 1.91 US$18,583
2022-01-14 2022-01-13
S Sale
7,209 -0.2%
1.93
US$13,886 		7,209 -0.2% 1.93 US$13,886
2022-01-14 2022-01-12
S Sale
4,634 -0.1%
2.02
US$9,357 		4,634 -0.1% 2.02 US$9,357
2022-01-11 2022-01-11
S Sale
2,409 -0.1%
2.04
US$4,919 		2,409 -0.1% 2.04 US$4,919
2022-01-11 2022-01-10
S Sale
1,751 -0.1%
2.00
US$3,502 		1,751 -0.1% 2.00 US$3,502
2022-01-11 2022-01-07
S Sale
14,600 -0.4%
2.08
US$30,318 		14,600 -0.4% 2.08 US$30,318
2022-01-06 2022-01-06
S Sale
10,257 -0.3%
2.16
US$22,205 		10,257 -0.3% 2.16 US$22,205
2022-01-06 2022-01-05
S Sale
8,200 -0.2%
2.25
US$18,439 		8,200 -0.2% 2.25 US$18,439
2022-01-06 2022-01-04
S Sale
13,459 -0.4%
2.34
US$31,544 		13,459 -0.4% 2.34 US$31,544
2022-01-03 2022-01-03
S Sale
44,665 -1.2%
2.34
US$104,396 		44,665 -1.2% 2.34 US$104,396
2022-01-03 2021-12-31
S Sale
49,953 -1.4%
2.25
US$112,409 		49,953 -1.4% 2.25 US$112,409
2022-01-03 2021-12-30
S Sale
21,858 -0.6%
2.29
US$50,066 		21,858 -0.6% 2.29 US$50,066
2020-05-22 2020-05-20
S Sale
420,000 -12.7%
3.66
US$1,535,562 		420,000 -12.7% 3.66 US$1,535,562
2020-03-16 2020-03-16
B Purchase
475,000 +13.4%
16.00
US$7,600,000 		475,000 +13.4% 16.00 US$7,600,000
2020-03-10 2020-03-06
S Sale
708,155 -29.2%
6.99
US$4,950,003 		708,155 -29.2% 6.99 US$4,950,003
2020-02-12 2020-02-10
B Purchase
1,250,000 +25.1%
12.00
US$15,000,000 		1,250,000 +25.1% 12.00 US$15,000,000
2020-04-13 2019-08-28
S Sale
1,211 -0.0%
2.91
US$3,524 		1,211 -0.0% 2.91 US$3,524
2019-03-06 2019-03-05
B Purchase
3,750,000 +46.1%
4.00
US$15,000,000 		3,750,000 +46.1% 4.00 US$15,000,000